Quarterly report pursuant to Section 13 or 15(d)

Financing Arrangements (Notes Payable) (Details)

v2.4.0.8
Financing Arrangements (Notes Payable) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended 12 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Notes Payable, Current and Noncurrent [Abstract]    
Net carrying amount $ 193,631 $ 0
Current notes payable 337 9,109
Total notes payable 193,968 9,109
2019 convertible senior notes
   
Notes Payable, Current and Noncurrent [Abstract]    
Principal amount outstanding 245,000 0
Unamortized discount (51,369) 0
Net carrying amount 193,631 0
Convertible notes payable, Viking Therapeutics, Inc.
   
Notes Payable, Current and Noncurrent [Abstract]    
Current notes payable 337 0
Current portion notes payable, 8.64%, due August 1, 2014
   
Notes Payable, Current and Noncurrent [Abstract]    
Current notes payable 0 6,642
Maturity Date of Loan Aug. 01, 2014 Aug. 01, 2014
Interest rate 8.64% 8.64%
Current portion notes payable, 8.9012%, due August 1, 2014
   
Notes Payable, Current and Noncurrent [Abstract]    
Current notes payable $ 0 $ 2,467
Maturity Date of Loan Aug. 01, 2014 Aug. 01, 2014
Interest rate 8.9012% 8.9012%